Mohammad Ariful Islam

Mohammad Ariful Islam, PhD, is a Principal Scientist and mRNA Drug Product Leader at Sanofi, where they engage in mRNA formulation discovery and process development. With a strong background in RNA technology, they have extensive experience in developing robust RNA formulations for vaccine and gene therapy applications. Previously, they held research fellowships at Harvard Medical School and Brigham and Women's Hospital, focusing on nanomedicine and mRNA delivery systems. Mohammad received their PhD in Biomedical Engineering and Gene Therapy from Seoul National University and has also contributed to several collaborative projects across prestigious institutions including MIT and Boston Children's Hospital.